Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study-Reference-Cited by-同舟云学术

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

Published:2006-03 Issue:3 Volume:7 Page:223-229
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Domchek Susan M,Friebel Tara M,Neuhausen Susan L,Wagner Theresa,Evans Gareth,Isaacs Claudine,Garber Judy E,Daly Mary B,Eeles Rosalind,Matloff Ellen,Tomlinson Gail E,Van't Veer Laura,Lynch Henry T,Olopade Olufunmilayo I,Weber Barbara L,Rebbeck Timothy R

Publisher

Elsevier BV

Subject

Oncology

Reference14 articles.

1. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations;Rebbeck;N Engl J Med,2002

2. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation;Kauff;N Engl J Med,2002

3. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers;Rebbeck;J Natl Cancer Inst,1999

4. Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer;Peters;Genet Test,2005

5. Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study;Keogh;Cancer Epidemiol Biomarkers Prev,2004

Cited by 290 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation;Journal of Gynecologic Oncology;2025

2. Hereditary Cancer Genetic Testing;Delaware Journal of Public Health;2024-08

3. Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomy;Obstetrics & Gynecology Science;2024-07-15

4. Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations;JAMA Oncology;2024-04-01

5. Prophylactic Interventions for Hereditary Breast and Ovarian Cancer Risks and Mortality in BRCA1/2 Carriers;Cancers;2023-12-24